Enzymatica AB (publ) (STO:ENZY)
Sweden · Delayed Price · Currency is SEK 2.590
+0.390 (17.73%)
Nov 4, 2026, 5:29 PM CET
Enzymatica AB Market Cap
Enzymatica AB has a market cap or net worth of 628.68 million as of November 4, 2026. It is the 29,285th most valuable company in the world and the 383rd biggest in Sweden. Its market cap has increased by 32.48% in one year.
Market Cap
628.68M
Enterprise Value
635.79M
Revenue
51.49M
Global Rank
Country Rank
#383 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 14, 2011, Enzymatica AB's market cap has increased from 108.93M to 628.68M, an increase of 477.16%. That is a compound annual growth rate of 12.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 628.68M | 36.32% |
| Dec 30, 2025 | 461.20M | 35.28% |
| Dec 30, 2024 | 340.92M | -47.39% |
| Dec 29, 2023 | 647.99M | -12.33% |
| Dec 30, 2022 | 739.16M | -43.36% |
| Dec 30, 2021 | 1.31B | -51.13% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanexa AB | 1.99B |
| Dicot Pharma AB | 752.71M |
| EQL Pharma AB | 671.80M |
| Cereno Scientific AB | 528.85M |
| Cinclus Pharma Holding AB | 519.36M |
| Moberg Pharma AB | 509.55M |
| Klaria Pharma Holding AB (publ.) | 133.57M |
| Vivesto AB | 81.82M |